News
Detailed price information for Psyence Biomedical Ltd (PBM-Q) from The Globe and Mail including charting and trades.
Pharmalittle: We’re reading about Trump team moving on pharma tariffs, PBMs under pressure, and more
Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...
PI (Physik Instrumente), a global leader in precision motion control and nanopositioning systems, is pleased to announce progress in the construction of its new production facility in Shrewsbury, ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch ...
Attorney General Gordon C. Rhea of the U.S. Virgin Islands has joined a bipartisan coalition of 38 attorneys generalfrom ...
UnitedHealth is the parent company of Optum Rx, one of the biggest PBMs. A PBM helps employer-sponsored health plans and ...
THE OWNERS BLAME PHARMACY BENEFIT MANAGERS OR PBMS. PBMS ARE THE MIDDLEMEN IN THE PHARMACY SUPPLY CHAIN. THEY DECIDE HOW MUCH A PHARMACY IS PAID FOR THE DRUGS THEY DISPENSE. OFTEN IT’S NOT ...
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria . Approval based on phase 3 studies demonstrating Dupixent signifi ...
A survey has indicated that the tariffs imposed by President Donald Trump‘s administration may not lead to a resurgence in U.S. manufacturing. What Happened: A new supply chain survey suggested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results